PMV PHARMACEUTICALS INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PMVP
PMV Pharmaceuticals, Inc. is a precision oncology company. The Company is engaged in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a well-defined tumor suppressor protein known as the guardian of the genome, and normal, or wild type, p53 has the ability to eliminate cancer cells. It is deploying its precision oncology platform to target p53 mutations and other p53-related cancers. Its lead product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. In addition to its rezatapopt program, it is focused on developing a pipeline of product candidates targeting other p53 mutations or p53-related targets. These programs have been developed using its precision oncology platform.
Find out what a historical investment in PMV PHARMACEUTICALS INC would be worth today using our PMVP stock calculator.
$68.11M
-
0.00%
618
$1.30
$1.26
$0.00
$1.84
$0.81
Ready to start your investing journey with Stake?
Open an accountPMVP FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PMVP
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PMVP
on Stake
Buy PMVP from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PMVP from only US$10 with fractional shares
